The Complete Hospice DME Formulary Guide: What It Is and Why It Matters

The Formulary Is More Than a List

Many hospice administrators think of the formulary as a document, a PDF in the policy folder, a spreadsheet that gets reviewed annually, a reference guide for clinical staff. That framing undersells what the formulary actually is and what it can do.

A well-managed hospice DME formulary is an operational strategy. It translates clinical philosophy, what equipment best serves patients at each stage of illness, into an administrative structure that governs ordering, controls cost, supports compliance, and creates consistency across a large clinical team. Done right, the formulary is the engine of a hospice's DME program.

Done poorly, or ignored entirely, it becomes a source of formulary drift, compliance exposure, and financial hemorrhage that is very difficult to diagnose until it's already caused significant damage.

What a Formulary Actually Is

A hospice DME formulary is a pre-approved list of equipment items organized by category and tier, specifying what the hospice covers under its Medicare Part A benefit, at what level of clinical review, and under what conditions.

Most formularies have an In Formulary and Out of Formulary structure:

In Formulary. Items that are standard for the hospice's patient population and can be ordered by clinical staff without special review. Hospital beds, standard Group I mattresses, commodes, 5-liter oxygen concentrators, walkers, standard wheelchairs. These items are ordered routinely because the clinical justification is predictable and the cost is manageable.

Out of Formulary. All items that would be considered non-standard, including higher priced items. These include special chairs like Broda's, higher end respiratory items like Bi-PAPs and CPAPs, as well as special mattresses or overlays. Additional higher priced items will also fall here, but there is an opportunity to add controls that provide guardrails to help manage costs.

Out of Formulary Requiring Pre-Authorization. High-cost or specialized items can be designated for approval from designated team members before ordering. This can be unique to your organization and shaped over time depending on where you want your focus to be. These items can include low air loss mattresses, bariatric equipment, and portable oxygen concentrators.

Why the Formulary Matters for Cost

The connection between formulary management and DME cost is direct and significant. Here is how formulary failure manifests financially:

Formulary drift. Over time, without active management, ordering patterns drift upward. Clinical staff begin ordering high cost items without review. These items appear on invoices without prior authorization records. Off-formulary products get ordered because a vendor offered them or a nurse prefers them. Each individual decision may seem minor; the cumulative effect is a meaningfully higher cost per patient per day.

Off-formulary creep. A single clinical staff member who regularly orders a premium pressure mattress rather than the standard formulary item may cost the hospice hundreds of dollars per patient per month. Multiply that pattern across a large clinical team, and the formulary impact is significant.

Missed benchmarking. Hospices without a managed formulary have no baseline against which to measure their spending. They can't identify whether their DME cost per patient per day is high or low, or which categories are driving cost above expectations. The formulary creates the framework for meaningful benchmarking.

For hospices with an average daily census of 50 patients, disciplined formulary management, combined with vendor network optimization, can generate savings of $50,000 or more annually. At higher census volumes, the savings scale proportionally.

Why the Formulary Matters for Compliance

The formulary isn't just a cost management tool. It has significant compliance implications:

Consistent documentation. When ordering is governed by a formulary with defined authorization levels, every order has a documented basis. Formulary items are ordered by patient need. Non-formulary items carry an indicator when ordered to flag the added cost. Non-formulary items that require authorization go through an approval process.

Off-formulary accountability. When off-formulary items are ordered, as they sometimes legitimately need to be, the approval process creates a decision trail. Without that process, off-formulary items appear on invoices with no controls.

How to Structure an Effective Hospice DME Formulary

An effective formulary is built on two foundations:

Clinically sound equipment selection. Hospice care isn't governed by the kind of evidence-based protocols you'd see in acute care. The formulary should instead reflect what best supports comfort and quality of life at each stage of a patient's illness, informed by clinical judgment and the realities of the hospice's patient population. This isn't just about cost minimization, it's about making sure clinical staff have the right tools available and that the formulary supports rather than impedes good care. A formulary that excludes equipment that patients actually need creates pressure to work around it, which creates compliance risk.

A review cadence that matches your contracts. Formularies are often locked into vendor contracts, some running three years, with pricing tied directly to what is and isn't included. That means the formulary itself typically can't be adjusted annually. What can and should happen more often is a review of the non-formulary and pre-authorization items against actual invoices. A quarterly look at what's showing up off-formulary gives you the chance to decide whether new controls, tiers, or authorization requirements are worth introducing before your next contract cycle.

Managing Off-Formulary Requests

Off-formulary requests are inevitable. Some patients have needs that fall outside what the formulary contemplates, and denying those needs would be a clinical failure, not a cost success.

The goal is not to eliminate off-formulary ordering. It is to ensure that:

Off-formulary orders reflect a genuine patient need. The person submitting the request should be able to point to what this patient needs that the formulary doesn't provide, and why. In practice, the person placing the order isn't always a clinician, and a full written clinical justification usually isn't required. But that core question, what does this patient need that the formulary doesn't cover, is still the right one to ask.

Off-formulary decisions are made at the level that fits your organization. Some hospices centralize approval for high-cost off-formulary items with a clinical reviewer. Others fully empower bedside nurses to make that call. Neither approach is inherently right or wrong. What matters is that the hospice has intentionally decided where that authority sits, rather than letting it default by habit.

The Role of a DME Benefits Manager in Formulary Management

Most hospices don't have the internal infrastructure to maintain a well-managed formulary. Clinical staff are focused on patient care. Administrative staff may lack the DME expertise to evaluate formulary decisions. Leadership lacks real-time use data.

A DME Benefits Manager like Qualis provides the infrastructure that makes active formulary management possible:

Use data. Real-time visibility into what is being ordered, by whom, through which vendors, and at what cost, by item, category, and patient. This data makes formulary drift visible before it becomes a budget problem.

Peer benchmarking. Comparing your hospice's formulary and ordering patterns against similar organizations reveals where you're above benchmark and in which categories. Benchmarking turns cost management from guesswork into a data-driven discipline.

Clinical education support. Helping clinical staff understand why the formulary is structured as it is, and what the compliance and financial implications of off-formulary ordering are, is part of effective formulary governance.

Formulary design consultation. Building a formulary from scratch, or significantly revising an existing one, benefits from expertise in hospice DME clinical standards and market pricing.

Frequently Asked Questions

What happens if a patient needs something not on the formulary?

The off-formulary request process is the appropriate pathway. The ordering individual indicates the reason via a dropdown menu, and the request goes to a qualified reviewer, often alongside someone with financial oversight like a CFO, since off-formulary items carry a real cost tradeoff. The reviewer approves or denies the request, and the decision is documented. If approved, the item can be ordered through the vendor network.

Who is responsible for formulary decisions in a hospice?

Typically a combination of clinical leadership (DON or clinical director) and the medical director, with operational input from whoever manages DME. The formulary is a clinical document with financial implications, it should be owned at the leadership level.

How does the formulary affect the patient's experience of care?

When the formulary is designed well, patients receive the equipment they need promptly and without friction. When it's too restrictive, clinical staff feel constrained and patients may experience gaps. The goal is a formulary that governs ordering rigorously without impeding appropriate care.

Qualis is the nation's first DME Benefits Manager for hospice providers. We help hospices build, manage, and optimize DME formularies, providing the use data, peer benchmarking, and clinical education support that active formulary management requires.